- Home
- RGEN vs LLYVK Comparison
RGEN vs LLYVK Comparison
Compare RGEN & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGEN | LLYVK |
|---|---|---|
| Founded | 1981 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RGEN | LLYVK |
|---|---|---|
| Price | $156.66 | $85.20 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $170.90 | N/A |
| AVG Volume (30 Days) | ★ 696.6K | 359.0K |
| Earning Date | 10-28-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $707,890,000.00 | N/A |
| Revenue This Year | $17.84 | N/A |
| Revenue Next Year | $12.57 | $10.22 |
| P/E Ratio | $6,185.26 | ★ N/A |
| Revenue Growth | ★ 11.74 | N/A |
| 52 Week Low | $102.97 | $60.55 |
| 52 Week High | $182.52 | $102.62 |
Technical Indicators
Market Signals| Indicator | RGEN | LLYVK |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 56.14 |
| Support Level | $160.11 | $80.19 |
| Resistance Level | $165.02 | $83.58 |
| Average True Range (ATR) | 4.97 | 2.49 |
| MACD | -1.27 | 1.03 |
| Stochastic Oscillator | 7.12 | 86.60 |
Price Performance
Historical ComparisonAbout RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About LLYVK Liberty Media Corporation
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.